ストックスクリーナーアプリを入手
7.22
0.69%
-0.05
アフターアワーズ：
7.22
Rxsight Inc (RXST) 最新ニュース
Volume Summary: Will RxSight Inc benefit from geopolitical trends2026 Short Interest & Weekly Top Stock Performers List - baoquankhu1.vn
Trend Report: Is RxSight Inc forming a double bottom2026 Key Lessons & Stepwise Trade Signal Guides - baoquankhu1.vn
Retail Surge: Can RxSight Inc deliver consistent EPS growthWeekly Trend Summary & Fast Exit Strategy with Risk Control - baoquankhu1.vn
How (RXST) Movements Inform Risk Allocation Models - Stock Traders Daily
Needham Maintains RxSight (RXST) Buy Recommendation - MSN
RxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat
Gains Report: What is RxSight Incs valuation compared to sector2026 Intraday Action & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Market Moves: Will RxSight Inc stock hit new highs in YEARQuarterly Earnings Report & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Analysis Recap: Will RxSight Inc benefit from geopolitical trendsJobs Report & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Investment Recap: Will RxSight Inc benefit from geopolitical trendsSwing Trade & Stepwise Trade Signal Guides - baoquankhu1.vn
RxSight Inc stock: 300,000 Lens Milestone Signals Growth Potential - AD HOC NEWS
RxSight Reaches 300,000 Light Adjustable Lens Implant Milestone - National Today
RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 - Sahm
RxSight, Inc. (RXST) stock price, news, quote and history - Yahoo Finance Australia
RxSight reports 300,000 Light Adjustable Lens implants milestone By Investing.com - Investing.com South Africa
RxSight reports 300,000 Light Adjustable Lens implants milestone - Investing.com
RxSight reaches 300,000 Light Adjustable Lens implants since launch - StreetInsider
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Shareholders to Learn More About the Investigation | NDAQ:RXST | Press Release - Stockhouse
How The Story Is Shifting For RxSight (RXST) On Guidance Leadership And Valuation - Yahoo Finance
RXST PE Ratio & Valuation, Is RXST Overvalued - Intellectia AI
RxSight, Inc. (RXST) Stock Price, News, Quote & History - Yahoo! Finance Canada
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight to Participate in Annual Healthcare Conference - National Today
RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference - The Manila Times
RXST SEC FilingsRxsight, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
RxSight management joins Needham virtual healthcare event Apr. 16 - Stock Titan
Earnings Risk: Will RxSight Inc stock hit new highs in YEAR2026 Year in Review & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
RXST Should I Buy - Intellectia AI
Trading Systems Reacting to (RXST) Volatility - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Aug Volume: What is RxSight Incs revenue forecast2026 Risk Factors & Accurate Technical Buy Alerts - baoquankhu1.vn
Vanguard realignment: RXST filings show 0 shares; subsidiaries report separately (RXST) - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Retail Trends: Is RxSight Inc a top pick in the sector2026 Price Targets & Low Drawdown Momentum Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
RxSight, Inc.(NasdaqGM:RXST) dropped from S&P Healthcare Equipment Select Industry Index - MarketScreener
Volume Recap: What is RxSight Incs valuation compared to sectorQuarterly Profit Summary & Reliable Breakout Forecasts - baoquankhu1.vn
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Transition - Yahoo Finance
How Rxsight Inc. (RXST) Affects Rotational Strategy Timing - Stock Traders Daily
RxSight (NASDAQ: RXST) details CFO sign-on bonus and corrects option vesting - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Investors to Connect - ACCESS Newswire
Breakout Watch: What is RxSight Incs revenue forecast2026 Opening Moves & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Aug Intraday: What is RxSight Incs revenue forecast2026 Biggest Moves & Entry Point Strategy Guides - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
RXST Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Tech Rally: Is CNTY affected by consumer sentiment2026 Geopolitical Influence & Advanced Technical Signal Analysis - baoquankhu1.vn
RxSight, Inc. (NASDAQ:RXST) Given Consensus Rating of "Reduce" by Analysts - MarketBeat
US Stocks Recap: What are the risks of holding RF Acquisition Corp IIPortfolio Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Meridiem Capital Partners LP Buys New Position in RxSight, Inc. $RXST - MarketBeat
RxSight Inc Stock (ISIN: US78419L1008) Faces Analyst Pressure After Q4 Revenue Drop - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and RxSight (RXST) - The Globe and Mail
(RXST) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Stifel cuts RxSight stock price target to $9 on revenue guidance - Investing.com South Africa
Stifel Lowers Price Target for RxSight (RXST) Following Recent A - GuruFocus
Stifel Nicolaus Has Lowered Expectations for RxSight (NASDAQ:RXST) Stock Price - MarketBeat
2.40%
0.00%
大文字化:
|
ボリューム (24 時間):